{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:28:07Z","timestamp":1785788887248,"version":"3.56.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1097\/01.jcp.0000115663.45074.8a","type":"journal-article","created":{"date-parts":[[2004,9,2]],"date-time":"2004-09-02T00:08:23Z","timestamp":1094083703000},"page":"220-224","source":"Crossref","is-referenced-by-count":22,"title":["A Trial of Low Doses of Risperidone in the Treatment of Patients With First-Episode Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder"],"prefix":"10.1097","volume":"24","author":[{"given":"Zahid-Ul","family":"Huq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210128","first-page":"1183","article-title":"Duration of psychosis and outcome in first-episode schizophrenia.","volume":"149","author":"Loebel","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","article-title":"Phenothiazine treatment in acute schizophrenia.","volume":"10","author":"Cole","year":"1964","journal-title":"Arch Gen Psychiatry"},{"key":"R3-17-20210128","first-page":"519","article-title":"The Scottish first-episode schizophrenia study: II. Treatment: pimozide versus flupentixol.","volume":"153","year":"1987","journal-title":"Br J Psychiatry"},{"key":"R4-17-20210128","first-page":"92","article-title":"Treatment outcome of first episode schizophrenia patients.","volume":"25","author":"Lieberman","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"R5-17-20210128","first-page":"81","article-title":"Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia.","volume":"28","author":"Chakos","year":"1992","journal-title":"Psychopharmacol Bull"},{"key":"R6-17-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/ajp.153.4.519","article-title":"Course of treatment response in first-episode and chronic schizophrenia.","volume":"153","author":"Syzmanski","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R7-17-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00004714-199302000-00004","article-title":"A Canadian multicentre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.","volume":"13","author":"Chouinard","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0006-3223(95)00500-5","article-title":"Symptoms in neuroleptic naive, first episode schizophrenia: response to risperidone.","volume":"39","author":"Kopala","year":"1996","journal-title":"Soc Biol Psychiatry"},{"key":"R9-17-20210128","first-page":"S19","article-title":"Risperidone in first-episode schizophrenia: improvement in symptoms and pre-existing extrapyramidal signs.","volume":"2","author":"Kopala","year":"1998","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R10-17-20210128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/oxfordjournals.schbul.a033413","article-title":"Risperidone in the treatment of first-episode psychotic patients: a double-blind multicentre study.","volume":"25","year":"1999","journal-title":"Schizophr Bull"},{"key":"R11-17-20210128","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00004714-199708000-00011","article-title":"Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low dose risperidone.","volume":"17","author":"Kopala","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"R12-17-20210128","first-page":"1819","article-title":"Optimal risperidone dose in drug naive first episode schizophrenia.","volume":"151","author":"Kontaxakis","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R13-17-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.168.2.221","article-title":"Abnormal movements in never-medicated Indian patients with schizophrenia.","volume":"168","author":"McCreadie","year":"1996","journal-title":"Br J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.jcp.0000115663.45074.8a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:35:21Z","timestamp":1785785721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200404000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000115663.45074.8a","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}